261 related articles for article (PubMed ID: 23563849)
1. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Jun; 42(6):1883-9. PubMed ID: 23563849
[TBL] [Abstract][Full Text] [Related]
2. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
[TBL] [Abstract][Full Text] [Related]
3. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Oct; 43(4):1027-35. PubMed ID: 23900236
[TBL] [Abstract][Full Text] [Related]
4. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Jul; 43(1):39-49. PubMed ID: 23661254
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
[TBL] [Abstract][Full Text] [Related]
6. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2015 Jul; 47(1):370-6. PubMed ID: 25997494
[TBL] [Abstract][Full Text] [Related]
7. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2014 Aug; 45(2):887-94. PubMed ID: 24867464
[TBL] [Abstract][Full Text] [Related]
8. Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2009 Dec; 22(6):1283-91. PubMed ID: 19885578
[TBL] [Abstract][Full Text] [Related]
9. Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Int J Oncol; 2014 Mar; 44(3):986-92. PubMed ID: 24378964
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2010 Sep; 24(3):747-57. PubMed ID: 20664983
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
12. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
Liu Z; Ivanoff A; Klominek J
Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
[TBL] [Abstract][Full Text] [Related]
15. Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCα-p38 MAPK pathway-mediated progression of human liver cancer cells.
Ye JC; Hsieh YS; Chen PN; Liu JY; Hsieh YH
Drug Dev Res; 2023 Jun; 84(4):767-776. PubMed ID: 37005497
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases.
Harvey P; Clark IM; Jaurand MC; Warn RM; Edwards DR
Br J Cancer; 2000 Nov; 83(9):1147-53. PubMed ID: 11027427
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Exp Lung Res; 2006; 32(3-4):69-79. PubMed ID: 16754473
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
20. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
